Quality Management and Compliance - The company plans to integrate a year-long "special audit" program into the daily quality management system of subsidiaries in 2024, enhancing quality management capabilities [3]. - The company emphasizes maintaining credibility and brand integrity, implementing strict quality control measures to ensure the accuracy of testing reports [2]. - The company has established a dedicated department to monitor policy changes in the testing industry, mitigating potential risks from regulatory uncertainties [6]. - The company has implemented a comprehensive anti-corruption framework to uphold ethical standards and protect its brand reputation [5]. - The company has developed a "Quality Management Maturity Assessment" 2.0 to quantitatively evaluate the performance of subsidiary quality management departments [3]. - The company has implemented a year-long "special audit" program across subsidiaries to enhance the professionalism of audit personnel and improve the effectiveness of audit results, with plans to integrate this into daily quality management in 2024 [40]. - The company emphasizes the importance of maintaining credibility and brand integrity, implementing strict quality control measures to ensure compliance with international standards [102]. Financial Performance - The company's operating revenue for 2023 was RMB 5,604,624,525.83, representing a 9.24% increase compared to RMB 5,130,710,067.66 in 2022 [18]. - The net profit attributable to shareholders for 2023 was RMB 910,203,484.57, a slight increase of 0.83% from RMB 902,731,908.18 in the previous year [18]. - The net profit after deducting non-recurring gains and losses was RMB 783,729,247.84, showing a decrease of 1.81% from RMB 798,208,182.29 in 2022 [18]. - The net cash flow from operating activities for 2023 was RMB 1,122,394,756.87, which is a 1.99% increase from RMB 1,100,448,099.99 in 2022 [18]. - The total assets at the end of 2023 amounted to RMB 8,749,114,094.50, reflecting an 11.70% increase from RMB 7,832,630,435.63 at the end of 2022 [18]. - The net assets attributable to shareholders reached RMB 6,205,345,102.90, marking a 13.33% increase from RMB 5,475,514,893.90 in 2022 [18]. - The basic earnings per share for 2023 was RMB 0.5474, up 1.31% from RMB 0.5403 in the previous year [18]. - The diluted earnings per share also stood at RMB 0.5474, reflecting the same increase of 1.31% from RMB 0.5403 in 2022 [18]. - The weighted average return on equity for 2023 was 15.55%, a decrease of 2.63 percentage points from 18.18% in 2022 [18]. - The EBITDA for 2023 was RMB 1,521,161,965.79, which is a 1.67% increase from RMB 1,496,146,541.14 in the previous year [18]. Strategic Growth and Investments - The company is pursuing mergers and acquisitions as a key strategy for long-term growth, with a focus on thorough due diligence and integration post-acquisition [7]. - The company is actively managing capital expenditures and conducting detailed investment return analyses to ensure the rationality of its investments [9]. - The company is exploring new strategic directions in sectors such as pharmaceuticals, semiconductors, and carbon neutrality services to drive future growth [100]. - The company plans to maintain an active attitude towards mergers and acquisitions in 2024, enhancing its core competitiveness in this area and expanding into international markets, particularly in Southeast Asia [100]. - The company has established a postdoctoral innovation practice base, recruiting 9 postdoctoral researchers, with 5 having completed their tenure [46]. - The company has established a dedicated department to monitor policy changes in the testing industry, aiming to mitigate risks associated with government regulations [103]. - The company has conducted thorough budget management and investment return analysis for capital expenditures outside of mergers and acquisitions [104]. Research and Development - The company has obtained patent authorization for multiple R&D projects, enhancing its core competitiveness in various fields, including chip testing and automotive material aging tests [71]. - The company has developed a quantitative detection method for advanced glycation end products (AGEs), which enhances early disease diagnosis accuracy [79]. - The company has made advancements in the research of the inherent resonance frequency of battery packs under different temperatures, contributing to the reliability and safety of electric vehicle battery installations [77]. - The company has developed a cost-effective pathogen metagenomic tNGS detection method, enhancing its market share in pathogen detection products [79]. - The company has established standards for the performance and inspection of phased array ultrasonic equipment, promoting technological innovation in the non-destructive testing field [76]. Market Expansion and Internationalization - The company is actively exploring international development and enhancing its global service capabilities to improve its competitiveness in the international market [27]. - The company has established subsidiaries in Japan, South Korea, and Vietnam as part of its Southeast Asia development strategy, with Singapore serving as the overseas operational headquarters [60]. - The company is advancing its internationalization process and enhancing its brand influence, contributing to its long-term strategic goals [59]. - The company plans to enhance its internationalization efforts by building a global sales network and increasing international client growth in the consumer goods sector [60]. - The company is focusing on expanding its market presence and enhancing its service offerings through various guarantees and partnerships [197]. Environmental and Social Responsibility - The company is committed to maintaining compliance with environmental regulations and standards as part of its operational strategy [168]. - The company aims to set emission reduction targets in line with the Paris Agreement and scientific carbon goals by 2024 [176]. - The company has implemented green office practices, including promoting paperless processes and energy-saving measures, to reduce carbon emissions [176]. - The company encourages green commuting by prioritizing nearby employees for business travel and promoting online meetings to reduce travel frequency [177]. - The company conducted various charitable donations, including CNY 5,000 worth of supplies to a village in Anhui Province in June 2023 [180]. Governance and Management - The company maintains a governance structure that ensures equal treatment of all shareholders and independent operation from its controlling shareholder [108]. - The board of directors consists of 7 members, including 4 non-independent directors, complying with legal and regulatory requirements [109]. - The company has established a performance evaluation and incentive system linking management compensation to business performance [110]. - The company respects and protects the rights of stakeholders, promoting balanced interests among shareholders, employees, and society [110]. - The company has a complete internal control system that effectively prevents operational risks and protects investor rights [110].

Financial Performance - The company's revenue for Q1 2024 was CNY 1,191,912,757.30, representing a 6.70% increase compared to CNY 1,117,097,334.31 in the same period last year[3] - Net profit attributable to shareholders decreased by 8.12% to CNY 132,541,651.89 from CNY 144,260,702.30 year-on-year[3] - The total operating profit for Q1 2024 was CNY 139,634,679.89, a decrease from CNY 169,159,598.51 in Q1 2023[19] - The net profit for Q1 2024 was CNY 131,143,851.71, a decrease of 11.43% compared to CNY 148,109,863.17 in the same period last year[19] - The total comprehensive income for Q1 2024 was CNY 123,329,956.58, down from CNY 151,311,267.20 in Q1 2023[20] - Basic and diluted earnings per share for Q1 2024 were both CNY 0.0791, compared to CNY 0.0862 in Q1 2023[20] Cash Flow - The net cash flow from operating activities was negative at CNY -170,020,188.80, a decline of 603.16% compared to CNY -24,179,495.64 in the previous year[9] - The company reported a significant decrease in cash flow from investment activities, with net cash flow of CNY -135,754,429.47, a decline of 310.17% year-on-year[9] - Cash received from other operating activities amounted to CNY 38,636,516.94, down from CNY 101,203,072.17 in the previous year[21] - The net cash flow from investment activities was -135,754,429.47 CNY, compared to -33,096,865.24 CNY in the previous year[22] - The total cash outflow from financing activities was 69,640,353.84 CNY, down from 135,417,763.28 CNY year-over-year[22] - The net cash flow from financing activities was -58,380,362.86 CNY, compared to -131,753,643.28 CNY in the same quarter last year[22] - The cash and cash equivalents at the end of the period were 1,057,848,986.16 CNY, down from 1,386,964,555.65 CNY year-over-year[22] Assets and Liabilities - The total assets at the end of Q1 2024 were CNY 8,426,653,680.95, down 3.69% from CNY 8,749,114,094.50 at the end of the previous year[3] - The company's total liabilities decreased to CNY 1,872,706,020.45 from CNY 2,329,917,898.09, marking a reduction of approximately 19.6%[17] - The company’s total liabilities decreased by 3.69% compared to the previous year, reflecting a strategic focus on reducing debt[3] Shareholder Information - The total number of common shareholders at the end of the reporting period is 53,793, with the top 10 shareholders holding 39.35% of the shares[10] - Wan Feng, a domestic individual, holds 14.94% of the shares, amounting to 251,335,874 shares[10] - Hong Kong Central Clearing Limited, a foreign entity, holds 13.94% of the shares, totaling 234,548,087 shares[10] - Yu Cuiping, another domestic individual, owns 4.09% of the shares, which is 68,775,500 shares[10] - UBS AG, a foreign entity, holds 2.55% of the shares, equating to 42,948,874 shares[10] - The percentage of shares held by the top 10 shareholders represents a significant portion of the total equity, indicating concentrated ownership[12] Operating Costs and Expenses - Operating costs for Q1 2024 were ¥1,058,291,701.16, up 9.3% from ¥968,340,603.79 in the same period last year[18] - Net profit margin for Q1 2024 was impacted by increased operating costs, with a significant rise in sales expenses to ¥218,866,933.22, compared to ¥203,932,386.03 in Q1 2023[18] - Research and development expenses for Q1 2024 were ¥98,828,982.57, compared to ¥91,174,498.28 in Q1 2023, indicating an increase of 8.5%[18] Other Financial Metrics - The weighted average return on equity decreased to 2.12%, down 0.48 percentage points from 2.60% in the same period last year[3] - The company reported an increase in investment income of 87.55% to CNY 14,009,872.28, compared to CNY 7,469,850.38 in the same period last year[8] - The company recorded other comprehensive income after tax of CNY -7,813,895.13, compared to CNY 3,201,404.03 in Q1 2023[19] - The company received government subsidies amounting to CNY 16,338,574.38, which is a 41.24% decrease from CNY 27,804,387.74 in the previous year[8] - The company reported a credit impairment loss of CNY -7,902,919.52, an improvement from CNY -9,857,492.49 in the previous year[19]

证券代码：300012 证券简称：华测检测 公告编号：2023-076 华测检测认证集团股份有限公司 关于回购股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 华测检测认证集团股份有限公司（以下简称"公司"）于 2023 年 5 月 15 日召开第六届董事会第四次会议审议通过了《关于回购公司股份方案的议案》， 公司计划使用自有资金以集中竞价方式回购公司股份，回购的公司股份用于员工 持股计划或股权激励。本次拟回购股份数量为 300 万股-500 万股，回购股份价格 不超过人民币 25 元/股，按照回购数量上限 500 万股和回购价格上限 25 元/股的 条件下测算，预计回购金额不超过 12,500 万元，具体回购股份的数量以回购结束 时实际回购的股份数量为准。本次回购实施期限为自公司董事会审议通过本次回 购股份方案之日起不超过 12 个月。具体内容详见公司 2023 年 5 月 16 日、2023 年 5 月 18 日在巨潮资讯网（http://www.cninfo.com.cn）上披露的《关于回购公司 股份方案的公告》（公告编号：2023-033 ...

万云翔先生将其持有的"玄元科新 165 号私募证券投资基金、玄元科新 166 号私 募证券投资基金、玄元科新 260 号私募证券投资基金、玄元科新 261 号私募证券投资 基金、玄元科新 262 号私募证券投资基金、玄元科新 263 号私募证券投资基金、玄元 科新 264 号私募证券投资基金、玄元科新 265 号私募证券投资基金"的所有份额转让 给万峰先生。万云翔先生将其持有的博创21 号集合资产管理计划份额转让给万峰先生 的一致行动人万里鹏先生。转让完成后，万云翔先生与上述产品解除一致行动关系。 | | | 股东名称 | 转让前份额持有人 | 转让后份额持有人 | | --- | --- | --- | --- | --- | | 博创 | 21 | 号集合资产管理计划 | 万峰、万云翔 | 万峰、万里鹏 | | 玄元科新 | 165 | 号私募证券投资基金 | 万峰、万云翔 | 万峰 | | 玄元科新 | 166 | 号私募证券投资基金 | 万峰、万云翔 | 万峰 | | 玄元科新 | 260 | 号私募证券投资基金 | 万峰、万云翔 | 万峰 | | 玄元科新 | 261 | 号私募证券投资基金 | 万 ...

华测检测认证集团股份有限公司 关于一致行动人之间协议转让股份完成过户登记的公告 证券代码：300012 证券简称：华测检测 公告编号：2023-074 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、股份转让概述 华测检测认证集团股份有限公司（以下简称"公司"）持股 5%以上股东万云翔 先生于 2023 年 9 月 22 日与万峰先生签署了《华测检测认证集团股份有限公司股份 转让协议书》,将其所持有 130,501,554 股(占公司总股本的 7.75%，占公司剔除回 购专用账户中股份数量后总股本的 7.78%)公司股份通过协议转让的方式转让给 万峰先生，转让完成后万云翔先生不再持有公司股份。公司于 2023 年 9 月 23 日发 布了《关于一致行动人之间协议转让股份的提示性公告》及《简式权益变动报告书》。 2023 年 11 月 24 日，中国证券登记结算有限责任公司深圳分公司出具了《证券 过户登记确认书》，万云翔先生协议转让给万峰先生 130,501,554 股无限售流通股 份已于 2023 年 11 月 23 日完成了过户登记手续。 注：上述相关股 ...

证券代码：300012 证券简称：华测检测 公告编号：2023-073 华测检测认证集团股份有限公司 关于回购股份的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 华测检测认证集团股份有限公司（以下简称"公司"）于 2023 年 5 月 15 日召开第六届董事会第四次会议审议通过了《关于回购公司股份方案的议案》， 公司计划使用自有资金以集中竞价方式回购公司股份，回购的公司股份用于员工 持股计划或股权激励。本次拟回购股份数量为 300 万股-500 万股，回购股份价格 不超过人民币 25 元/股，按照回购数量上限 500 万股和回购价格上限 25 元/股的 条件下测算，预计回购金额不超过 12,500 万元，具体回购股份的数量以回购结束 时实际回购的股份数量为准。本次回购实施期限为自公司董事会审议通过本次回 购股份方案之日起不超过 12 个月。具体内容详见公司 2023 年 5 月 16 日、2023 年 5 月 18 日在巨潮资讯网（http://www.cninfo.com.cn）上披露的《关于回购公司 股份方案的公告》（公告编号：2023-033 ...

Financial Performance - The company's revenue for Q3 2023 reached ¥1,525,405,269.39, representing a 5.70% increase year-over-year, while the year-to-date revenue was ¥4,081,457,016.38, up 12.91% compared to the same period last year[3] - Net profit attributable to shareholders for Q3 2023 was ¥312,678,839.60, a 3.42% increase year-over-year, with a year-to-date net profit of ¥740,850,363.05, reflecting an 11.69% increase[3] - The basic earnings per share for Q3 2023 was ¥0.1862, up 3.33% year-over-year, and the diluted earnings per share was also ¥0.1862, showing a 3.33% increase[3] - Total operating revenue for Q3 2023 reached CNY 4,081,457,016.38, an increase of 12.92% compared to CNY 3,614,704,743.06 in Q3 2022[15] - Net profit attributable to shareholders of the parent company was CNY 740,850,363.05, up 11.69% from CNY 663,291,263.55 in the same period last year[16] - The total comprehensive income for the period was CNY 756,026,046.70, compared to CNY 666,225,805.22 in the same quarter last year, marking an increase of 13.49%[17] Assets and Liabilities - The company's total assets as of September 30, 2023, were ¥8,279,865,835.66, a 5.71% increase from the end of the previous year[3] - The equity attributable to shareholders increased to ¥6,077,710,339.67, marking an 11.00% rise compared to the end of the previous year[3] - The company's total liabilities decreased to CNY 1,987,215,646.72 from CNY 2,158,916,120.97, reflecting a reduction of approximately 7.93%[15] - The company's non-current liabilities increased to CNY 491,984,637.42 from CNY 452,312,167.34, representing an increase of 8.77%[15] - The company's total liabilities include short-term borrowings of RMB 15,803,508.10, a significant increase from RMB 2,002,750.00 at the beginning of the year[14] Cash Flow - The company reported a net cash flow from operating activities of ¥404,838,368.03 year-to-date, which is a decrease of 10.39% compared to the same period last year[3] - Cash generated from operating activities amounted to CNY 3,829,802,566.28, compared to CNY 3,288,335,522.78 in the previous year, indicating a growth of 16.51%[18] - The net cash inflow from operating activities was CNY 196,166,412.97, compared to CNY 184,253,678.96 in the previous year, showing an increase of 6.06%[18] - Net cash outflow from operating activities was CNY 3,621,130,611.22, compared to CNY 3,020,813,974.03 last year[19] - Net cash flow from operating activities amounted to CNY 404,838,368.03, down from CNY 451,775,227.71 in the same period last year[19] - The net increase in cash and cash equivalents was CNY -480,465,983.99, compared to an increase of CNY 56,832,925.67 in the same period last year[19] Shareholder Information - The total number of common shareholders at the end of the reporting period is 35,686, with the top 10 shareholders holding a combined 35.74% of shares[10] - The top shareholder, Hong Kong Central Clearing Limited, holds 10.74% of the shares, amounting to 180,790,025 shares[10] Investments and Acquisitions - The company acquired 52% equity in Anhui Fengxue Network Security Testing Co., Ltd. for a cash consideration of RMB 28.08 million on July 10, 2023[12] - The company established a new subsidiary, Huace Medical Device Technology Service (Shenzhen) Co., Ltd., approved on August 28, 2023[12] Operating Costs and Income - The total operating costs for Q3 2023 were CNY 3,280,193,068.75, up from CNY 2,914,313,777.03, indicating an increase of 12.55%[15] - The company reported a significant increase in fixed assets, rising to RMB 2,226,504,151.56 from RMB 1,725,607,152.39, marking an increase of approximately 29%[14] - The company reported a 167.13% increase in non-operating income, amounting to ¥5,353,288.01, primarily due to increased incidental gains[8] - The company reported a 32.00% increase in taxes and surcharges, totaling ¥23,390,490.58, mainly due to an increase in property tax[7]

证券代码：300012 证券简称：华测检测 公告编号：2023-072 华测检测认证集团股份有限公司 1、名称：成都经济技术开发区管理委员会 2、统一社会信用代码：11510100009270998Y （一）协议主体 关于公司对外投资暨签署项目投资协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、对外投资概述 华测检测认证集团股份有限公司（以下简称"公司"或"华测检测"）拟与成 都经济技术开发区管理委员会签署《华测检测西南区综合检测基地项目投资协议书 》，项目主要建设内容为投资建设华测检测西南区综合测试基地。项目计划总投资 约12亿元，资金来源为公司自筹资金。 根据《深圳证券交易所上市公司自律监管指引第2号——创业板上市公司规范运 作》等相关规定，本次事项在董事会的审议权限范围内，无需提交股东大会审议。 本次对外投资不构成关联交易，不构成《上市公司重大资产重组管理办法》规定的重 大资产重组，公司将按照相关法律法规规定办理具体事项和履行信息披露义务。 二、协议对方基本情况 甲方：成都经济技术开发区管理委员会 乙方：华测检测认证集团股份有限公司 3、 ...

第六届董事会第十次会议决议公告 证券代码：300012 证券简称：华测检测 公告编号：2023-070 华测检测认证集团股份有限公司 特此公告！ 华测检测认证集团股份有限公司 董 事 会 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 二○二三年十月二十五日 华测检测认证集团股份有限公司（以下简称"公司"）第六届董事会第十次会 议于 2023 年 10 月 13 日发出会议通知，2023 年 10 月 24 日以现场结合通讯方式召 开。本次会议应参与董事 7 名，实际参与董事 7 名，分别为：万峰、申屠献忠、 钱峰、戚观成、程海晋、曾繁礼、刘志权。会议由董事长万峰主持，董事会会议 的举行和召开符合国家有关法律、法规及《公司章程》的规定。经充分讨论和审 议，会议形成决议如下： 一、会议以 7 票同意、0 票反对、0 票弃权，审议通过《2023 年第三季度报 告全文》 公司《2023 年第三季度报告全文》具体内容详见在巨潮资讯网的相关公告。 二、会议以 7 票同意、0 票反对、0 票弃权，审议通过《关于公司对外投资暨 签署项目投资协议的议案》 董事会认为，公司本次 ...

公司《2023 年第三季度报告全文》具体内容详见巨潮资讯网的相关公告。 特此公告！ 华测检测认证集团股份有限公司 华测检测认证集团股份有限公司 第六届监事会第八次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 华测检测认证集团股份有限公司（以下简称"公司"）第六届监事会第八次 会议于 2023 年 10 月 13 日发出会议通知，2023 年 10 月 24 日以现场结合通讯方式 召开。本次会议应参加监事 3 人，实际参加监事 3 人，分别为：陈炜明、杜学志、 张渝民。本次会议召开符合《公司法》和《公司章程》的有关规定。会议由公司 监事会主席陈炜明先生主持，经与会监事认真审议，形成如下决议： 一、会议以 3 票同意、0 票反对、0 票弃权，审议通过《2023 年第三季度报告全 文》 监事会认为，公司董事会编制和审核的《2023 年第三季度报告全文》的程序 符合法律、行政法规、中国证监会和深交所的规定，报告的内容真实、准确、完 整地反映了公司的实际情况，不存在任何虚假记载、误导性陈述或者重大遗漏。 证券代码：300012 证券简称：华测检测 公告编 ...